Skip to content
zameds

Lisinopril (Austell Lisinopril, Austell-lisinopril, Austell-lisnopril)

Lisinopril

Austell Pharmaceuticals (Pty) Ltd

Registration

Applicant
Austell Pharmaceuticals (Pty) Ltd
Registrations
4

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Austell lisinopril 2,5 MG

EACH TABLET CONTAINS LISINOPRIL DIHYDRATE EQUIVALENT TO LISINOPRIL 2,5 mg

2,5 mg37039137/7.1.3/0391RegisteredNot determinedNone
Austell-lisinopril 20 MG

EACH TABLET CONTAINS LISINOPRIL DIHYDRATE EQUIVALENT TO LISINOPRIL 20,0 mg

20 mg37039237/7.1.3/0392RegisteredNot determinedNone
Austell-lisinopril 10 MG

EACH TABLET CONTAINS LISINOPRIL 10,0 mg

10 mg38003238/7.1.3/0032RegisteredNot determinedNone
Austell-lisnopril 5 MG

EACH TABLET CONTAINS LISINOPRIL 5,0 mg

5 mg38003338/7.1.3/0033RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S3: Hydrochlorothiazide

    Consolidated Schedules 06 July 2026, line 3721

  • S3: Lisinopril

    Consolidated Schedules 06 July 2026, line 3902

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C21H31N3O5405.50 g/mol

(2S)-1-[(2S)-6-Amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid

Drag to rotate. Structure from PubChem CID 5362119.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles